Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HKI-272 Administered Orally to Healthy Subjects.
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Pharmacokinetics; safety and tolerability; influence of food on the same.
United States: Food and Drug Administration
|Seattle, Washington 98195|